Aavantgarde Bio S.r.l.
- Address
- Via Uberto Visconti Di Modrone 18
Sponsor Overview
Specializations
Oncology and Cancer Therapeutics
Aavantgarde Bio S.r.l. focuses its research efforts on advancing cancer treatment through innovative therapeutic approaches. The company's clinical development program centers on addressing critical unmet needs in solid tumor malignancies, with particular emphasis on cancers affecting the gastrointestinal system.
- Gastric Cancer Treatment
- Solid Tumor Therapeutics
- Advanced Stage Cancer Management
The sponsor's research portfolio demonstrates a commitment to developing treatments for patients with advanced gastric cancer, targeting populations where existing therapeutic options may be limited. This work reflects a strategic focus on gastrointestinal oncology and the development of novel interventions for difficult-to-treat malignancies.
Precision Medicine and Targeted Therapies
The company's clinical investigation activities incorporate elements of precision oncology, with research designed to evaluate therapeutic interventions in specific cancer populations. The approach suggests an interest in developing treatments that may be tailored to particular disease characteristics or patient populations.
- Biomarker-Informed Treatment Strategies
- Patient-Specific Cancer Therapies
- Molecular Oncology Applications
This focus on targeted cancer treatment aligns with contemporary trends in oncology drug development, where understanding the molecular and biological characteristics of tumors guides therapeutic intervention strategies.
Sponsored Trials
| Trial Name | Country | Status |
|---|---|---|
| Phase 1/2 Study of Subretinal AAVB-081 Administration in Usher Syndrome Type 1B Retinitis Pigmentosa Patients |  Italy | Not Recruiting |
| Safety and Efficacy of Subretinal Administration of AAVB-039 in Participants with Stargardt Disease (STGD1): A Phase 1/2 Open-Label, Multicenter Study |  Belgium Italy Norway The Netherlands | Not Yet Recruiting |
Data & Insights
This sponsor works with 3 molecules, of which 2 are not being studied by other sponsors.
This sponsor has worked with 4 sites across their trial portfolio.
Therapeutic Focus
- 1.Eye Diseases2 trials138 other sponsors
- 2.Congenital, Hereditary, and Neonatal Diseases and Abnormalities1 trial165 other sponsors
Partnered Research Centres
4 centres- Address
- Piazza Luigi Miraglia 2, 80138 Naples
- Address
- Montebello, Ullernchausséen 70, 0379 Oslo
- Address
- Schiedamse Vest 180, 3011 BH Rotterdam
- Address
- Corneel Heymanslaan 10, 9000 Ghent
Want to get in touch with this sponsor?
Send a question and we'll pass it on to Aavantgarde Bio S.r.l..
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.